{
  "trial_id": "NCT01101880",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race/ethnicity, ECOG performance status, serum creatinine, estimated glomerular filtration rate (GFR), serum bilirubin, aspartate transferase (AST), alanine transferase (ALT), alkaline phosphatase, diagnosis (type of leukemia or myelodysplastic syndrome), percentage of blasts in bone marrow or peripheral blood, prior treatments for hematological disorders, presence of significant organ dysfunction, presence of systemic infection, pregnancy status, use of contraceptive methods, history of other malignancies, prior allogeneic stem cell transplant.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "ECOG performance status",
          "ECOG performance status"
        ],
        [
          "serum creatinine",
          "serum creatinine"
        ],
        [
          "estimated glomerular filtration rate (GFR)",
          "estimated glomerular filtration rate (GFR)"
        ],
        [
          "serum bilirubin",
          "serum bilirubin"
        ],
        [
          "aspartate transferase (AST)",
          "aspartate transferase (AST)"
        ],
        [
          "alanine transferase (ALT)",
          "alanine transferase (ALT)"
        ],
        [
          "alkaline phosphatase",
          "alkaline phosphatase"
        ],
        [
          "Antecedent hematological disorder (AHD)",
          "prior treatments for hematological disorders"
        ],
        [
          "Peripheral Blast",
          "percentage of blasts in bone marrow or peripheral blood"
        ],
        [
          "prior allogeneic stem cell transplant",
          "prior allogeneic stem cell transplant"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Cytogenetic Risk Factor",
        "FLT3 ITD mutation status",
        "WBC"
      ],
      "remaining_candidate_features": [
        "race/ethnicity",
        "diagnosis (type of leukemia or myelodysplastic syndrome)",
        "presence of significant organ dysfunction",
        "presence of systemic infection",
        "pregnancy status",
        "use of contraceptive methods",
        "history of other malignancies"
      ]
    },
    "processed-gen-response": "Age, gender, race/ethnicity, ECOG performance status, serum creatinine, estimated glomerular filtration rate (GFR), serum bilirubin, aspartate transferase (AST), alanine transferase (ALT), alkaline phosphatase, diagnosis (type of leukemia or myelodysplastic syndrome), percentage of blasts in bone marrow or peripheral blood, prior treatments for hematological disorders, presence of significant organ dysfunction, presence of systemic infection, pregnancy status, use of contraceptive methods, history of other malignancies, prior allogeneic stem cell transplant."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Serum Creatinine, Serum Bilirubin, Aspartate Transferase (AST), Alanine Transferase (ALT), Alkaline Phosphatase, Bone Marrow Blasts Percentage, Peripheral Blood Blasts Percentage, Prior Hematological Disorders,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Antecedent hematological disorder (AHD)",
          "Prior Hematological Disorders"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Serum Creatinine",
          "Serum Creatinine"
        ],
        [
          "Serum Bilirubin",
          "Serum Bilirubin"
        ],
        [
          "Aspartate Transferase (AST)",
          "Aspartate Transferase (AST)"
        ],
        [
          "Alanine Transferase (ALT)",
          "Alanine Transferase (ALT)"
        ],
        [
          "Alkaline Phosphatase",
          "Alkaline Phosphatase"
        ],
        [
          "Peripheral Blast",
          "Peripheral Blood Blasts Percentage"
        ]
      ],
      "remaining_reference_features": [
        "Cytogenetic Risk Factor",
        "FLT3 ITD mutation status",
        "WBC"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Bone Marrow Blasts Percentage"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Serum Creatinine, Serum Bilirubin, Aspartate Transferase (AST), Alanine Transferase (ALT), Alkaline Phosphatase, Bone Marrow Blasts Percentage, Peripheral Blood Blasts Percentage, Prior Hematological Disorders"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Serum Creatinine, Serum Bilirubin, AST/ALT, Alkaline Phosphatase, Diagnosis of Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Myeloproliferative Neoplasm, Prior Treatment with Hydroxyurea, Imides, or Hypomethylating Agents.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Serum Creatinine",
          "Serum Creatinine"
        ],
        [
          "Serum Bilirubin",
          "Serum Bilirubin"
        ],
        [
          "AST/ALT",
          "AST/ALT"
        ],
        [
          "Alkaline Phosphatase",
          "Alkaline Phosphatase"
        ]
      ],
      "remaining_reference_features": [
        "Cytogenetic Risk Factor",
        "Antecedent hematological disorder (AHD)",
        "FLT3 ITD mutation status",
        "WBC",
        "Peripheral Blast"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Diagnosis of Acute Myeloid Leukemia",
        "Myelodysplastic Syndrome",
        "or Myeloproliferative Neoplasm",
        "Prior Treatment with Hydroxyurea",
        "Imides",
        "or Hypomethylating Agents."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Serum Creatinine, Serum Bilirubin, AST/ALT, Alkaline Phosphatase, Diagnosis of Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Myeloproliferative Neoplasm, Prior Treatment with Hydroxyurea, Imides, or Hypomethylating Agents."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, serum creatinine, estimated glomerular filtration rate, serum bilirubin, aspartate transferase, alanine transferase, alkaline phosphatase, diagnosis (AML, MDS, MPN), cytogenetics (11q23, del(5q), inv(16), t(15;17), t(16;16), t(8;21)), prior therapy (hydroxyurea, imides, hypomethylating agents).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Cytogenetic Risk Factor",
          "cytogenetics (11q23, del(5q), inv(16), t(15;17), t(16;16), t(8;21)"
        ],
        [
          "ECOG performance status",
          "ECOG performance status"
        ],
        [
          "serum creatinine",
          "serum creatinine"
        ],
        [
          "estimated glomerular filtration rate",
          "estimated glomerular filtration rate"
        ],
        [
          "serum bilirubin",
          "serum bilirubin"
        ],
        [
          "aspartate transferase",
          "aspartate transferase"
        ],
        [
          "alanine transferase",
          "alanine transferase"
        ],
        [
          "alkaline phosphatase",
          "alkaline phosphatase"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Antecedent hematological disorder (AHD)",
        "FLT3 ITD mutation status",
        "WBC",
        "Peripheral Blast"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "diagnosis (AML, MDS, MPN)",
        "prior therapy (hydroxyurea, imides, hypomethylating agents)"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG performance status, serum creatinine, estimated glomerular filtration rate, serum bilirubin, aspartate transferase, alanine transferase, alkaline phosphatase, diagnosis (AML, MDS, MPN), cytogenetics (11q23, del(5q), inv(16), t(15;17), t(16;16), t(8;21)), prior therapy (hydroxyurea, imides, hypomethylating agents)."
  }
}